Effect of Diabetes Mellitus and Metformin Usage on Treatment Outcomes and Side Effects on Prostate Cancer Treated with Radical Radiotherapy

被引:1
作者
Dagdelen, Meltem [1 ]
Barlas, Ceren [1 ]
Yildirim, Cumhur [1 ]
Karacam, Songul Cavdar [1 ]
Dincbas, H. Fazilet Oner [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Radiat Oncol, Istanbul, Turkey
来源
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2021年 / 20卷 / 03期
关键词
Prostate cancer; diabetes mellitus; metformin; radiotherapy; side effects; THERAPY; HYPERGLYCEMIA; ASSOCIATION; MANAGEMENT; RECURRENCE; MORTALITY;
D O I
10.4274/uob.galenos.2020.1830
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Diabetes mellitus (DM) is a common comorbidity in patients with prostate cancer. Radiotherapy was reported to induce acute and late side effects in patients with DM due to vascular damage. Moreover, some studies have shown that metformin, an oral antidiabetic drug, can reduce biochemical and disease recurrence in patients with prostate cancer. This study aimed to evaluate retrospectively the effect of metformin on biochemical disease control and to observe the acute and late side effects of prostate cancer treated with radiotherapy. Materials and Methods: This study enrolled 94 patients who received radical radiotherapy between 2010 and 2017. However, out of 22 patients with DM, 17 received metformin and five received metformin plus insulin treatment. Biochemical recurrence-free survival (bRFS), overall survival, and side effects were assessed between patients with and without DM. Results: The median follow-up time was 57 (15-128) months. The 5-year bRFS rate in patients with and without DM were 100% and 89.2%, respectively (p=0.10). Acute grade 1-2 side effects were observed in all patients with DM, while 56 (78%) patients without DM had acute side effects, and the difference is significant (p=0.02). Acute grade 3 genitourinary and gastrointestinal toxicity was found in one patient without DM, whereas late grade 3 gastrointestinal toxicity was observed in one patient with DM. Conclusion: Although patients with DM were found to have better bRFS than patients without DM, we could not show the benefit of metformin, and the difference was not significant. By contrast, acute side effects were significantly higher in patients with DM.
引用
收藏
页码:162 / 167
页数:6
相关论文
共 22 条
[1]  
Akin M, 2014, TUMORI J, V100, P529, DOI 10.1700/1660.18172
[2]   What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal study [J].
Alashkham, Abduelmenem ;
Paterson, Catherine ;
Hubbard, Stephen ;
Nabi, Ghulam .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 14 :59-63
[3]   Obesity and cancer: mechanistic insights from transdisciplinary studies [J].
Allott, Emma H. ;
Hursting, Stephen D. .
ENDOCRINE-RELATED CANCER, 2015, 22 (06) :R365-R386
[4]   Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis [J].
Barone, Bethany B. ;
Yeh, Hsin-Chieh ;
Snyder, Claire F. ;
Peairs, Kimberly S. ;
Stein, Kelly B. ;
Derr, Rachel L. ;
Wolff, Antonio C. ;
Brancati, Frederick L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (23) :2754-2764
[5]   The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J].
Ben Sahra, I. ;
Laurent, K. ;
Loubat, A. ;
Giorgetti-Peraldi, S. ;
Colosetti, P. ;
Auberger, P. ;
Tanti, J. F. ;
Le Marchand-Brustel, Y. ;
Bost, F. .
ONCOGENE, 2008, 27 (25) :3576-3586
[6]   Prevalence of Diagnosed Diabetes in Adults by Diabetes Type - United States, 2016 [J].
Bullard, Kai McKeever ;
Cowie, Catherine C. ;
Lessem, Sarah E. ;
Saydah, Sharon H. ;
Menke, Andy ;
Geiss, Linda S. ;
Orchard, Trevor J. ;
Rolka, Deborah B. ;
Imperatore, Giuseppina .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (12) :359-361
[7]  
Careyva B, 2016, AM FAM PHYSICIAN, V94, P980
[8]   Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis [J].
Coyle, C. ;
Cafferty, F. H. ;
Vale, C. ;
Langley, R. E. .
ANNALS OF ONCOLOGY, 2016, 27 (12) :2184-2195
[9]   Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis [J].
Deng, Dan ;
Yang, Yuan ;
Tang, Xiaojun ;
Skrip, Laura ;
Qiu, Jingfu ;
Wang, Yang ;
Zhang, Fan .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (06) :595-602
[10]   The Influence of Statin Medications on Prostate-specific Antigen Levels [J].
Hamilton, Robert J. ;
Goldberg, Kenneth C. ;
Platz, Elizabeth A. ;
Freedland, Stephen J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (21) :1511-1518